A bis-amide bis-phenoxi N 2 O 2 ligand was obtained from the 2:1 molar reaction of phenyl salicylate and the diamine, 1,3-Diamino-2-2-dimethylpropane, to yield H 4 L. The ligand has been characterised by elemental analysis, IR, and 1 H and 13 C NMR spectroscopies, mass spectrometry (ES) and X ray diffraction spectroscopy.
INTRODUCTION
Our interest in this type of ligands derives from the known ability of ligands containing amide groups to stabilise high oxidation states of metal ions when coordinated with the deprotonated nitrogen atom. The oxygen amide atom of these ligands can act as a bridge between neighbouring metallic atoms and afford multi-dimensional and supramolecular structures. For this purpose, we selected the tetraionic H 4 L bisamido-bisphenoxy ligand. We have thought that the utilization of tetranionic bis-amide bisphenoxi ligands should favour the aggregation of neighbouring complexes through these donors atoms 1 (amide and phenoxo oxygen). In previous papers we reported on the synthesis, structures and properties of Mn(III) complexes with asymmetrical trianionic amido-imino-phenoxo ligands. Herein, we present the tetranionic ligand, H 4 L n that contain six potential donor atoms: two amide nitrogen, two phenoxo and two amide oxygen atoms.
RESULTS AND DISCUSSION
H 4 L were prepared according to the literature 2 , in this case by reaction in a 2:1 molar reaction of phenyl salicylate and the diamine at 180-190 º for 1 h. The product was treated with diethyl ether to obtain a white powder at almost quantitative yield. White crystals of H 4 L, suitable for single crystal Xray diffraction studies, were obtained by slow evaporation of methanol solution of the ligand. The compound was also characterised by elemental analysis, IR, and 1 H and 13 C NMR spectroscopy. Crystal data and structure refinement for H 4 L are listed in table 1. Crystal structure, with the numbering scheme, is shown in figure 1 . Selected bond lengths and angles, as well as potential hydrogen bonds and bonding scheme, are listed in table 2 and table 3. In the crystal structure of the title ligand (2) 148 (4) C (2) 
